This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38404338
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel bài báo khoa học wissenschaftlicher Artikel scienca artikolo artículu científicu espublizáu en 2016 artigo científico (publicado na 2016) مقالة علمية 2016年论文 επιστημονικό άρθρο tieteellinen artikkeli 2016 nî lūn-bûn artikulong pang-agham videnskabelig artikel (udgivet 2016) 2016年论文 مقالهٔ علمی գիտական հոդված article scientific мақолаи илмӣ naučni članak articolo scientifico наукова стаття, опублікована в листопаді 2016 article scientifique (publié 2016) scientific article 2016年论文 2016年論文 scientific article vitenskapelig artikkel 2016年の論文 2016年論文 wetenschappelijk artikel 2016년 논문 سائنسی مضمون artigo científico (publicado na 2016) 2016年论文 bilimsel makale 2016年論文 mokslinis straipsnis บทความทางวิทยาศาสตร์ articol științific научна статия artigo científico 2016年论文 artikull shkencor מאמר מדעי научни чланак 2016年論文 vědecký článek ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikel ilmiah 2016年论文 tudományos cikk სამეცნიერო სტატია artículo científico publicado en 2016 vedecký článok artykuł naukowy vetenskaplig artikel scientific article 2016年論文 мақолаи илмӣ научни чланак teaduslik artikkel article científic научная статья
p:P577
wds:Q38404338-919438D1-4A0E-4721-A71F-A7F00F37759A
wdt:P577
2016-11-17T00:00:00Z
p:P2860
wds:Q38404338-7532374F-2915-4B40-A9B1-93DAA9E937CF wds:Q38404338-79949B58-4FA9-4247-90CB-7411188C8B39 wds:Q38404338-8538EAC8-CB9B-430F-BAEB-40FD31DD3FA5 wds:Q38404338-9C834786-F966-4AF2-856B-602E51B6AC2A wds:Q38404338-9E52CAAD-7FD7-49F9-B050-7BEB7B6CA0B9 wds:Q38404338-A56DEE25-69D4-4EDD-91D7-3F42DE5EA014 wds:Q38404338-357946CE-3DFD-4121-A69B-FCE621F480A4 wds:Q38404338-435FA60C-3C63-4E62-9441-7C84C14C6287 wds:Q38404338-492C758B-234C-479C-8A2B-8104DB5B316C wds:Q38404338-4953DC8F-2966-4C4A-8DF1-8FF02363D36D wds:Q38404338-E7C56514-B201-43F8-B58C-8D8062C7AE1C wds:Q38404338-AA7714FF-2FB1-4C30-A39D-85704F4AADA3 wds:Q38404338-B4CEF116-549D-4260-8644-2D0A52ED33B6 wds:Q38404338-B7301C31-3E90-4191-917C-9BD17C202079 wds:Q38404338-BCCCA6A7-8BBD-4DED-B455-1E5A74F900CE wds:Q38404338-C8F2FC0B-170E-4DC1-AB88-3BC325B698C7 wds:Q38404338-CB09FC0B-1F12-4C9A-AA83-EA5250BC873B wds:Q38404338-066E2865-4E50-4B4C-84CE-11B7E7826E25 wds:Q38404338-354A20AA-073F-45D9-AAAE-C28AAA5F477D
wdt:P2860
wd:Q28274454 wd:Q38012942 wd:Q35203211 wd:Q43761720 wd:Q45220653 wd:Q34479098 wd:Q34274829 wd:Q36475336 wd:Q40677108 wd:Q46897299 wd:Q34400871 wd:Q46674433 wd:Q47677340 wd:Q37412866 wd:Q34432003 wd:Q42639526 wd:Q38130111 wd:Q41490656 wd:Q38138191
p:P2093
wds:Q38404338-E93B4545-486D-49EA-AC94-A68DAFCC0989 wds:Q38404338-D7A09A30-EEEC-4B90-B09F-3B00ADC2ED60 wds:Q38404338-DF671CA5-4A01-48B2-B9C7-7E1BD2CA5C11
wdt:P2093
Michael C David Remo Ostino Susan E Tett
rdfs:label
Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia
skos:prefLabel
Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia
schema:name
Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia Ezetimibe: Use, costs, and adverse events in Australia
p:P50
wds:Q38404338-F0E1E28C-461D-4EDC-91D3-75E25D8DA28D wds:Q38404338-E4F8A24C-1FA6-4252-BACF-D3B71E5ED6A1
wdt:P50
wd:Q43060208 wd:Q44551189
p:P1476
wds:Q38404338-331AA056-402B-49B6-8DD9-874BF6B4A4C3
wdt:P1476
Ezetimibe: Use, costs, and adverse events in Australia
p:P304
wds:Q38404338-EADFC04B-266D-4750-B226-A207030A3B4B
wdt:P304
40-46
p:P31
wds:Q38404338-6DC5BF6D-B93E-48B8-8428-DE1C1EA1FC8B
wdt:P31
wd:Q13442814
p:P921
wds:Q38404338-6B859B11-6322-421A-B6A1-CCB8348B0829
wdt:P921
wd:Q408
p:P698
wds:Q38404338-46638DFB-FA14-4FA9-BE08-CB646723F346
wdtn:P698
n9:27860332
wdt:P698
27860332
p:P1433
wds:Q38404338-E5586CB4-BDA7-48AC-B3AD-6630835B18E7
wdt:P1433
wd:Q1871490
p:P433
wds:Q38404338-1DA76E60-C1EA-485D-9F79-849A0466EECC
p:P478
wds:Q38404338-4F33FD7B-0B82-4EF1-9F98-6A7296C6834F
wdt:P433
1
wdt:P478
35
p:P356
wds:Q38404338-9C7A1C3A-BF9B-417F-B666-C94FCBCD585E
wdtn:P356
n11:1755-5922.12236
wdt:P356
10.1111/1755-5922.12236